A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
History of Coronary Heart Disease Increases the Mortality Rate of Coronavirus Disease 2019 (COVID-19) Patients: A Nested Case-Control Study Based on Publicly Reported Confirmed Cases in Mainland China
[article]
2020
medRxiv
pre-print
China has experienced an outbreak of a novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since December 2019, and it was announced a worldwide pandemic in March 2020. There is limited evidence on the mortality risk effect of pre-existing comorbidity for clinical disease (coronavirus disease 2019 [COVID-19]), which has important implications for early treatment. Objective: To evaluate the risk of the common preexisting comorbidities, including hypertension,
doi:10.1101/2020.03.23.20041848
fatcat:yzbfvzx5a5hxjjdmojexyu574e